ArticleBMC cancer2025

Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting.

Lijuan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.